Thanks! You've successfully subscribed to the BONEZONE®/OMTEC® Monthly eNewsletter!

Please take a moment to tell us more about yourself and help us keep unwanted emails out of your inbox.

Choose one or more mailing lists:
BONEZONE/OMTEC Monthly eNewsletter
OMTEC Conference Updates
Advertising/Sponsorship Opportunities
Exhibiting Opportunities
* Indicates a required field.

Lucideon and STC Offer Wear and Medical Device Testing Seminars in China

Lucideon, a materials technology company, and Hong Kong Standards and Testing Centre (STC), a testing, inspection and certification organization based in Hong Kong and China, are offering a series of seminars on wear testing and medical device testing to orthopaedic implant manufacturers and their supply chain in the Asia region.

The seminars will be held on May 24, 2016 at STC’s new facility in Dongguan and on May 26 in Shanghai.

Topics covered in the seminars will include ISO and ASTM standards for orthopaedic implant testing, mechanics of AMTI and ProSIM multi-station simulators for upper and lower limb joints and regulatory requirements for FDA approvals. Adverse testing, such as third-body abrasion, impingement, micro-separation and aging will also be included, as will wear debris analysis, ion release testing and surface characterization.

Dr Qianqian Wang, an expert in wear testing and head of Lucideon’s facilities in the U.K., will run the seminars. In addition to knee and hip implants, he will also cover spine, ankle and shoulder joints and talk about ancillary services to wear and fatigue testing, such as debris and wear pattern analysis.

During the seminar, STC will also introduce its new facilities for biocompatibility testing.

To sign up for the seminars, visit www.lucideon.com/china-seminars.

Source: Lucideon

Since the beginning of 2016, two large orthopaedic suppliers have either expanded existing operations or opened new facilities in China. Orchid acquired Cam Bioceramics’ coating facility in the nation, and then expanded its offerings with Vacuum Titanium Plasma Spray at its Suzhou site. In January, Eurocoatings and Surface Dynamics opened a new facility in Shanghai with a goal of being operational by the end of 2016.

The Chinese market is attractive to orthopaedic companies because of its aging population, increasing per capita wealth and increase in common health conditions such as diabetes and obesity. To determine if the Chinese market is right for your product, and if it can clear international regulatory hurdles, attend the OMTEC 2016 session “Strategies for Device Approval in China, India, South Korea and Australia.